Seel,

What does the MDA news mean in terms of what will actually have to be done before testing could be done on humans?  How long would they have to do pre-clinicals prior to being able to run a clinical?  Could the trial run after the first of the year after MTD reached?

Isn't this something like that already being done in Italy with myeloma?  I know Italy is testing with another drug so all is well but nice to see that Kevetrin appears to be so highly regarded toward this particular line of cancer.